# Colecalciferol as an Add-on Treatment to Interferon-beta-1b for Treatment of Multiple Sclerosis (MS)

> **NCT01339676** · PHASE4 · UNKNOWN · sponsor: **University of Turku** · enrollment: 70 (actual)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **DRUG:** Colecalciferol
- **DRUG:** Placebo capsules

## Key facts

- **NCT ID:** NCT01339676
- **Lead sponsor:** University of Turku
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-03
- **Primary completion:** 2011-05
- **Final completion:** 2011-06
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2011-05-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01339676

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01339676, "Colecalciferol as an Add-on Treatment to Interferon-beta-1b for Treatment of Multiple Sclerosis (MS)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01339676. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*